Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2004 | 1 |
2005 | 1 |
2009 | 1 |
2010 | 1 |
2016 | 1 |
2017 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Case Report: Marked Survival Advantage of Two Colorectal Cancer Patients with Liver Metastases Treated with Vigil and FOLFOX-6.
Vaccines (Basel). 2021 Oct 18;9(10):1201. doi: 10.3390/vaccines9101201.
Vaccines (Basel). 2021.
PMID: 34696309
Free PMC article.
Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer.
Oh J, Barve M, Matthews CM, Koon EC, Heffernan TP, Fine B, Grosen E, Bergman MK, Fleming EL, DeMars LR, West L, Spitz DL, Goodman H, Hancock KC, Wallraven G, Kumar P, Bognar E, Manning L, Pappen BO, Adams N, Senzer N, Nemunaitis J.
Oh J, et al. Among authors: adams n.
Gynecol Oncol. 2016 Dec;143(3):504-510. doi: 10.1016/j.ygyno.2016.09.018. Epub 2016 Sep 24.
Gynecol Oncol. 2016.
PMID: 27678295
Clinical Trial.
Item in Clipboard
A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors.
Nemunaitis J, Tong AW, Nemunaitis M, Senzer N, Phadke AP, Bedell C, Adams N, Zhang YA, Maples PB, Chen S, Pappen B, Burke J, Ichimaru D, Urata Y, Fujiwara T.
Nemunaitis J, et al. Among authors: adams n.
Mol Ther. 2010 Feb;18(2):429-34. doi: 10.1038/mt.2009.262. Epub 2009 Nov 24.
Mol Ther. 2010.
PMID: 19935775
Free PMC article.
Clinical Trial.
Item in Clipboard
Characterization of a novel prostate-specific antigen-activated peptide-doxorubicin conjugate in patients with prostate cancer.
DiPaola RS, Rinehart J, Nemunaitis J, Ebbinghaus S, Rubin E, Capanna T, Ciardella M, Doyle-Lindrud S, Goodwin S, Fontaine M, Adams N, Williams A, Schwartz M, Winchell G, Wickersham K, Deutsch P, Yao SL.
DiPaola RS, et al. Among authors: adams n.
J Clin Oncol. 2002 Apr 1;20(7):1874-9. doi: 10.1200/JCO.2002.07.001.
J Clin Oncol. 2002.
PMID: 11919247
Clinical Trial.
Item in Clipboard
Case Report: Immune-mediated Complete Response in a Patient With Recurrent Advanced Ewing Sarcoma (EWS) After Vigil Immunotherapy.
Ghisoli M, Rutledge M, Stephens PJ, Mennel R, Barve M, Manley M, Oliai BR, Murphy KM, Manning L, Gutierrez B, Rangadass P, Walker A, Wang Z, Rao D, Adams N, Wallraven G, Senzer N, Nemunaitis J.
Ghisoli M, et al. Among authors: adams n.
J Pediatr Hematol Oncol. 2017 May;39(4):e183-e186. doi: 10.1097/MPH.0000000000000822.
J Pediatr Hematol Oncol. 2017.
PMID: 28338569
Item in Clipboard
Phase I trial of an all-oral combination chemotherapy regimen: topotecan and capecitabine in solid tumor patients.
Nemunaitis J, Adams N, Cunningham C, Senzer N, Graham S, Barrera D, Nugent J, Stewart C.
Nemunaitis J, et al. Among authors: adams n.
J Oncol Manag. 2005 Summer;14(3):77-90.
J Oncol Manag. 2005.
PMID: 16161645
Clinical Trial.
Item in Clipboard
Phase I trial of topotecan in combination with gemcitabine in refractory solid tumor patients.
Nemunaitis J, Cunningham CC, Vukelja S, Ruxer RL, Adams N, Rich D, Paulson AS, MacEachern JB.
Nemunaitis J, et al. Among authors: adams n.
Cancer Invest. 2004;22(3):360-7. doi: 10.1081/cnv-200029060.
Cancer Invest. 2004.
PMID: 15493356
Clinical Trial.
Item in Clipboard
Cite
Cite